Jennison Associates LLC Sells 2,199,180 Shares of Phreesia, Inc. (NYSE:PHR)

Jennison Associates LLC lessened its stake in shares of Phreesia, Inc. (NYSE:PHR) by 98.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 38,778 shares of the company’s stock after selling 2,199,180 shares during the period. Jennison Associates LLC’s holdings in Phreesia were worth $898,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. International Assets Investment Management LLC raised its stake in shares of Phreesia by 1,987.3% during the fourth quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock valued at $34,000 after acquiring an additional 1,411 shares in the last quarter. Acadian Asset Management LLC purchased a new position in Phreesia during the third quarter valued at approximately $53,000. SG Americas Securities LLC purchased a new position in Phreesia during the third quarter valued at approximately $132,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Phreesia by 44.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,433 shares of the company’s stock valued at $214,000 after buying an additional 3,518 shares during the period. Finally, Raymond James & Associates purchased a new position in Phreesia during the fourth quarter valued at approximately $226,000. Institutional investors own 92.10% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on PHR shares. DA Davidson reissued a “neutral” rating and set a $32.00 price objective on shares of Phreesia in a report on Friday, March 15th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price objective on shares of Phreesia in a report on Friday, March 15th. Barclays started coverage on shares of Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price objective on the stock. Truist Financial initiated coverage on shares of Phreesia in a report on Monday, February 26th. They set a “buy” rating and a $35.00 price objective on the stock. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 price target on shares of Phreesia in a report on Thursday, March 21st. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $31.62.

Insider Transactions at Phreesia

In other news, COO Evan Roberts sold 25,962 shares of Phreesia stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $23.52, for a total transaction of $610,626.24. Following the completion of the sale, the chief operating officer now directly owns 728,570 shares in the company, valued at $17,135,966.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CFO Balaji Gandhi sold 3,504 shares of the business’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $23.21, for a total transaction of $81,327.84. Following the completion of the transaction, the chief financial officer now directly owns 94,030 shares in the company, valued at $2,182,436.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Evan Roberts sold 25,962 shares of the business’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $23.52, for a total transaction of $610,626.24. Following the transaction, the chief operating officer now owns 728,570 shares of the company’s stock, valued at $17,135,966.40. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 82,989 shares of company stock worth $1,911,735. Company insiders own 5.80% of the company’s stock.

Phreesia Stock Up 0.7 %

NYSE:PHR opened at $20.61 on Friday. Phreesia, Inc. has a 12 month low of $12.05 and a 12 month high of $34.98. The firm has a fifty day simple moving average of $23.66 and a 200-day simple moving average of $21.43. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The business had revenue of $95.00 million during the quarter, compared to the consensus estimate of $93.52 million. During the same period in the previous year, the firm posted ($0.72) earnings per share. The business’s revenue for the quarter was up 24.0% compared to the same quarter last year. As a group, research analysts expect that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.